24th Jun 2015 08:33
LONDON (Alliance News) - Premaitha Health PLC on Wednesday said new clinical data on its IONA non-invasive pre-natal test was presented at the World Congress in Fetal Medicine on Monday.
Premaitha said the data, presented by Brenda Kelly, consultant obstetrician and fetal medicine specialist at Oxford University Hospitals NHS Trust, showed the results from the IONA test were 100% accurate with no false positives.
The data was based on the analysis of 442 patient samples from six clinical sites in the UK. Trisomy 21 was detected in 43 samples, Trisomy 18 in 10 samples and Trisomy 13 in five samples. Trisomy is a very rare condition, also known as Edward's Syndrome, which can cause severe developmental delays.
"To have such influential fetal medicine consultants lead clinical studies for the IONA test is a great endorsement of its capabilities. We are delighted with the results and the opportunity to present at this prestigious international conference," said Premaitha Chief Medical Officer William Denman.
Shares in Premaitha were up 3.7% to 26.1751 pence on Wednesday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Premaitha Health